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ABSTRACT We have used biochemical and morphological techniques to demonstrate that
hepatocytes in the perfused liver bind, internalize, and degrade substantial amounts of murine
epidermal growth factor (EGF) via a receptor-mediated process . Before ligand exposure, about
300,000 high-affinity receptors were detectable per cell, displayed no latency, and co-
distributed with conventional plasma membrane markers. Cytochemical localization using
EGF coupled to horseradish peroxidase (EGF-HRP) revealed that the receptors were distributed
along the entire sinusoidal and lateral surfaces of hepatocytes . When saturating concentrations
of EGF were perfused through a liver at 35°C, ligand clearance was biphasic with a rapid
primary phase of 20,000 molecules/min per cell that dramatically changed at 15-20 min to a
slower secondary phase of 2,500 molecules/min per cell. During the primary phase of uptake,
approximately 250,000 molecules of EGF and 80% of the total functional receptors were
internalized into endocytic vesicles which could be separated from enzyme markers for plasma
membranes and lysosomes on sucrose gradients. The ligand pathway was visualized cyto-
chemically 2-25 min after EGF-HRP internalization and a rapid transport from endosomes at
the periphery to those in the Golgi apparatus-lysosome region was observed (t,% = 7 min) .
However, no 1251-EGF degradation was detected for at least 20 min . Within 30 min after EGF
addition, a steady state was reached which lasted up to 4 h such that (a) the rate of EGF
clearance equaled the rate of ligand degradation (2,500 molecules/min per cell); (b) a constant
pool of undegraded ligand was maintained in endosomes; and (c) the number of accessible
(i .e., cell surface) receptors remained constant at 20% of initial values. By 4 h hepatocytes had
internalized and degraded 3 and 2.3 times more EGF, respectively, than the initial number of
available receptors, even in the presence of cycloheximide and without substantial loss of
receptors . All of these results suggest that EGF receptors are internalized and that their rate of
recycling to the surface from intracellular sites is governed by the rate of entry of ligand and/
or receptor into lysosomes.
Receptor-mediated endocytosis (REM)' is well-recognized as
a general mechanism used by many cells to take up biolog-
' Abbreviations used in this paper:
￿
APDE, alkaline phosphodiester-
ase; ASGP, asialoglycoprotein; ,B-NAG, a-N-acetyl-glucosaminidase;
EGF, epidermal growth factor; EGF-HRP, conjugateofEGF to HRP,
horseradish peroxidase; 5'-NUC, 5'-nucleotidase; Gal-Trans, galac-
tosyl-transferase; LDL, low-density lipoprotein; RME, receptor-me-
diated endocytosis; S1, 0.25 M sucrose in 3 mM imidazole, pH 7.4;
TCA, trichloroacetic acid; 12-K fraction, liver fraction sedimenting
at 12,000 g.
ically important molecules. The variety of molecules taken
up by RME include polypeptide hormones (e.g., epidermal
growth factor [EGF] and insulin), transport proteins carrying
nutritional and regulatory substances (e.g., low density-lipo-
protein (LDL)-cholesterol, transcobalamin 11-vitamin 1312),
lysosomal enzymes, asialoglycoproteins (ASGPs), and im-
munoglobulins (reviewed in reference 1). The destinations of
these interiorized molecules vary from degradation in the
lysosomal system with release of amino acids and monosac-
charides (e.g., ASGP [2]) orof regulatory molecules (e.g., LDL
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graded form (e.g., yolk proteins [3]) to transport across the
cytoplasm and subsequent exocytosis (e.g., immunoglobulins
[3, 4]). The fates of the surface receptors interacting with
specific ligands also vary from apparent reutilization during
prolonged periods of activity (e.g., LDL and ASGP receptors
[5, 6]) to loss of receptors after an initial wave of RME and
subsequent desensitization of cells (e.g., hormonal "down-
regulation" of EGF [7-11] or insulin [12, 13]). Thus, it is
clear that eucaryotic cellscarry out diverse functions that rely
on the selective process of RME.
The principle cell in the liver, the parenchymal cell or
hepatocyte, takes up many different molecules from the cir-
culation via RME. These include ASGPs (2, 14), insulin (15),
glucagon (16), prolactin (17), EGF (9, 18), transcobalamin II
(19), haptoglobin-hemoglobin complexes (20), hemopexin-
iron (21), glycoproteins with oligosaccharide chains terminat-
ing in a1,3 fucose residues (22), and immunoglobulin A (4).
All of these molecules are internalized via receptor-mediated
processes occurringat the sinusoidal surface ofthe hepatocyte.
In addition, the fates of the ligands and of their receptors
appear to encompass all currently established fates in RME.
Therefore, the hepatocyte is particularly suitable for a com-
parative study of selected ligand-receptor systems, each hav-
ing a different fate.
In recent years, we have been studying various aspects of
ASGP endocytosis by hepatocytes (14, 23-26). This RME
system represents one in which the ligand is ultimately deliv-
ered to and degraded within lysosomes but the receptor is
reused. Hepatocytes also endocytose and degrade substantial
amounts of EGF from the circulation but, unlike the ASGP
receptor, they appear to down-regulate the EGF receptor.
There is some evidence in cultured cells that the EGF receptor
is delivered to lysosomes and degraded together with the
ligand. However, no correlation has yet been made between
the amount of EGF processed by these cells and the number
ofreceptors lost.
Using the perfused liver, we have examined the kinetics of
EGF uptake and degradation and the pathway of ligand entry
from the cell surface to the lysosomes, both morphologically
and biochemically. We have quantitated the amount ofligand
internalized and degraded and compared these values with
the number of receptors (i.e., nonlatent, latent, and total)
present. Our results demonstrate that exposure to EGF in-
duces a redistribution of hepatocyte receptor from the cell
surface to an internal site (endosomes) but that these receptors
are reutilized, since more ligand molecules are internalized
than total functional receptors present, even when protein
synthesis is inhibited. Portions of this study have been pre-
sented elsewhere in abstract form (27).
MATERIALS AND METHODS
Materials
Horseradish peroxidase (HRP, type VI), 3-amino-1,2,4-triazole, 3,3'-dia-
minobenzidine (grade II), polyethylene glycol (8,000 mol wt), and mannan
were purchased from Sigma Chemical Co. (St. Louis, MO); HEPES was from
Research OrganicsInc. (Cleveland, OH); Brij 35 was from Pierce Chemical Co.
(Rockford, IL); BSA, fraction V, was from Miles Laboratories Inc. (Elkhart,
IN); and ultra-pure sucrose was obtained from Schwarz/Mann Inc. (Spring
Valley, NY). Carrier-free Na"I and uridinediphospho-D-[6-'Hlgalactose were
obtained from Amersham Corp. (Arlington Heights, IL). Male rats (CD strain)
were supplied by Charles River (Wilmington, MA). All other reagents and
compounds were of the highest purity available and were purchased from
commercial sources.
Preparation and Iodination of EGF
EGF was purified from male mouse submaxillary glands (Pel-Freez, Rogers,
AR) as described by Savage and Cohen (28). Protein concentrations were
calculated from the absorbance at 280 nm using an extinction coefficient at 10
mg/ml of 30.9 (29). EGF was iodinated by the chloramine T method (30) with
resulting specific radioactivities of20-150,000 cpm/ng.
Isolated Perfused Liver System
Livers from 24-h fasted rats (150-250 g) were surgically removed and
perfusedin a recycling system with a balanced salt solution supplemented with
2% polyvinyl pynolidone-40 (26) and oxygenated with 95% 02/5% C02-
SURF A C E B IN D I NG OF EG F:
￿
We quantitated exposed EGF receptors
by recirculating a saturatingdose of '2'I-EGF (4-8 j ug, 6-12 nM) at 4°C and at
periodic intervals removing 0.2-0.5 ml samples from the perfusing medium for
determination of the radioactive content. After 90-120 min, the bound '25I-
EGF was dissociated by addition of 5 ml of 1 M Na acetate pH 3.5, which
lowered the medium pH to 5.0. The amount of EGF bound was quantitated
either from the percent of radioactivity cleared from the perfusate, from the
radioactivity present in a liver homogenate before acid treatment, or from the
amount of bound radioactivity released when the perfusate was acidified. All
three measurementsyielded similarresults. EGF binding capacitywas expressed
as micrograms of EGF bound per gram wet weight of liver and converted to
receptors per hepatocyte using 1 .38 x 108 hepatocytes/g wet wt of liver (3 l)
and assuming a 1 :I interaction for the ligand-receptor complex.
ENDOCYTOSIS AND METABOLISM OF EGF :
￿
10-25 ug(15-38 nM) of
"'I-EGF was recirculated at 37°C for 4-240 min, and at timed intervals acid-
soluble and insoluble radioactivity was determined in 0.2-0.5-ml aliquots of
perfusate (see below). After terminating the uptake by cooling the liver to 4°C,
we removed surface-bound EGF by acidifying the perfusing medium as de-
scribed above and subsequently re-equilibrating the liver with cold, fresh
perfusate. For subcellular fractionations, the liver was disconnected from the
perfusion system before acidification, weighed, and homogenized. In vitro
binding assays were performed on liver biopsies (0.3-0.5 g) excised before
ligand addition and after removal ofsurface-bound ligand.
In Vitro EGF BindingAssay
EGF binding was measured in vitro (32) on aliquots of liver homogenates
(1 .5-2 mg protein), subeellular fractions (1-2 mg protein), and fractions ob-
tained from sucrose gradients. Samples were incubated with saturating doses
(80 nM) of '251-EGF (20-100,000 cpm/ng) for 60 min at 4°C in a total volume
of 0.2 ml that contained 20 mM HEPES, pH 7.4, and 0.5% BSA. Since
maximal EGF binding was observed within 30 min, these assay conditions
represent steady-state. Binding was terminated by the sequential addition of
0.5 ml of 0.1 % bovine IgG in 0.1 M phosphate buffer, pH 7.4, and 0.5 ml of
25% polyethylene glycol. The precipitatedEGF-receptor complexwascollected
under gentle vacuum on Whatman GF/C filters (Whatman Laboratory Prod-
ucts Inc., Clifton, NJ) soaked in 0.1 % BSA in 20 mM HEPES, pH 7.4, the
filters were washed with 15 ml of 10% polyethylene glycol in 0.1 M phosphate
buffer pH 7.4, and the radioactivity was retained on the filters measured. The
difference between '2'I-EGF binding in the absence and presence ofa 50-fold
molar excess of unlabeled EGF was taken as specific binding. Nonspecific
binding ranged between 10 and 20% oftotal radioactivity bound and was <1 %
of the total radioactivity added to the incubation. With liver homogenates,
binding capacity was expressed as micrograms ofEGF bound per gram of liver
or per milligram of protein. The number of receptors per cell was determined
as described above or by using a calculated conversion factor of 1 x 106
hepatocytes/mgprotein based on the wet weight ofunperfused livers.
The difference between specific '2'I-EGF-binding sites measured in the
presence (total) and absence (accessible) ofdetergent was defined as latent EGF
receptors. As described in Results, Brij 35 was the most effective detergent in
exposing latent receptors (detectable only after exposure of livers to EGF, see
Results). Detergent was added along with the ligand and at several concentra-
tions in order to obtain maximal EGF binding. A concentration of 0.2% (wt/
wt) was sufficient for sucrose gradient fractions, while a range of0.4-0.7% (wt/
wt) was necessary when homogenatesor subcellular fractionswere assayed.
Preparation and Characterization of HRP
Conjugated to EGF (EGF-HRP)
The procedure of Sell et al. (33) with modifications was used to couple the
N-terminal amino group of EGF (containing trace amounts of"'I-EGF)tothe
carbohydrate portion ofHRP. Uncoupled EGFwas removed from the mixture
by dialysis (Amicon PM-10 Amicon Corp., Danvers, MA). Using this proce-
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2149dure, 22% oftheadded "'I-EGF was coupled to the HRP, and the final product
retained at least 50% of the initial peroxidase activity (34). Analysis on SDS
polyacrylamide gels revealed that 82% of the radiolabel migrated with an
apparent molecular weight of 45,000 which was coincident with the major
stained band and similar in electrophoretic mobility to the uncoupled HRP.
The remaining radioactivity was distributed between a polypeptide at 90
kdaltons (14%), which presumably represented HRP dimers plus at least one
EGF, and uncoupled EGF at 6 kdaltons (4%).
125I-EGF-HRP binding measured in vitro with liver homogenates was spe-
cific and had an apparent dissociation constant of 15 nM, which is within the
range determined for unconjugated "I-EGF (Fig. 1). Inclusion ofmannan had
no effect, indicating that there was no binding in homogenates via the HRP
moiety.
Localization of EGF-HRP in the Perfused Liver and
Quantitation of HRP-containing Structures
EGF-HRP (4 wg of EGF) was perfused through a liver at 4°C for 120 min.
5 mgofmannan wasincluded asa precaution toinhibit binding ofthe conjugate
via the HRP moiety to mannose/N-acetyl-glucosamine receptors on nonpar-
enchymal cells (14). Unbound ligand was removed and the liver was either
immediately fixed by perfusion with 2% glutaraldehyde in 0.1 M sodium
cacodylate, pH 7.4, or warmed to >30°C for 2-25 min and then fixed.
Peroxidase activity in the fixed liver was visualized using the method ofWall
et al. (25). The presence of EGF-HRP in specific regions of the hepatocyte
cytoplasm (as defined in reference 25) wasquantitated eitherat the microscope
or on electron micrographs by counting the number of structures (regardless of
size) containing HRP reaction product.
Subcellular Fractionation of Liver Homogenates
Livers were weighed and homogenized in 5 vol of0.25 M sucrose in 3 mM
imidazole buffer, pH 7.4 (SI), and the following fractions were prepared
(Beckman centrifuge, 60 Ti rotor, Beckman Instruments Inc., Palo Alto, CA):
a 12,000 gm, (10 min) pellet (12-K fraction), a 145,000 g_ (90 min) pellet
(microsomal fraction), and a 145,000 gm, (90 min) supernate (cytosolic frac-
tion) (35). The 12-K pellet was resuspended in SI (5 ml/g liver) using a loose
Dounce homogenizer and 5 ml (65-85 mg of protein) was applied to the top
ofa linear 1 .11-1 .25 g/cc sucrose gradient (32 ml). The microsomal pellet was
resuspended in 15 ml ofSI with a Potter-Elvejhem homogenizer, and 5 ml (50-
60 mg of protein) was applied to a 1 .06-1 .20 g/cc linear sucrose gradient (28
ml) that was made above a 4 ml cushion of 1 .22 g/cc sucrose. After centrifuga-
tion of both gradients for 12-15 h at 83,000 g.,- in an SW28 Beckman rotor,
1 .2-ml fractions were collected from the top using a Buchler Auto Densi-Flow
fractionator (Buchler Instruments Inc., Fort Lee, NJ).
Analytical Procedures
Perfusate and liver homogenates (0.3-0.5 ml) were precipitated with 10%
trichloroacetic acid (TCA) in the presence of 0.2-1% BSA at 4°C for 60 min.
The samples were centrifuged (3,000 rpm for 15 min), supernate and pellet
were separated, and the radioactivity in each was determined in a Beckman
Gamma4000 counter. Acid-soluble radiolabeled products released by the liver
into the perfusion medium were further analyzed by column chromatography.
Sephadex G-25 medium (PD-10 columns, Pharmacia Inc., Piscataway, NJ)
equilibrated with 1 M acetic acid was used to separate free iodide from
iodotyrosine derivatives (36).
Protein was determined in triplicate following the procedure of Bradford
(37) using BSA as as standard. 5'-nucleotidase (5'-NUC) was assayed by
measuring the release of phosphate from adenosine monophosphate (38).
Alkaline phosphodiesterase (APDE) and B-N-acetyl-glucosaminidase (d-NAG)
activities were determined following published procedures (38). Galactosyl-
transferase (Gal-Trans) was assayed by monitoring the incorporation of ['H]-
galactose into ovalbumin (39).
RESULTS
Properties of EGF Binding
We first examined EGF binding in the isolated perfused
liver at 4°C (Fig. 1). Binding of EGF was both saturable and
reversible. Saturation occurred at EGF concentrations of 6-8
nM and yielded a maximum of 150,000 receptors per hepa-
tocyte (see below for cell type identification). The apparent
2150
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FIGURE 1
￿
Binding of 12'1-EGF in the isolated perfused liver and in
a liver homogenate. The indicated concentrations of 1251-EGF were
either perfused through livers (top panel) or incubated with liver
homogenates (bottom panel) at 4°C for 60-90 min. The amount of
EGF bound was then determined as described in Materials and
Methods and expressed as receptors per cell. A Scatchard plot of
the data obtained from liver homogenates is shown in the inset.
The straight line plot was computer fitted to the experimental values
(40). A similar plot for the perfused liver data could not be drawn
because each determination was done on livers of various weights
(5-9 g) which resulted in significant differences in total receptors
measured per ligand concentration. An EGF concentration of 80
nM was necessary to saturate the high-affinity sites in liver homog-
enates and therefore was routinely used throughout this study to
determine total available receptors in vitro. When standard error
bars are present, the value is an average ± SEM of at least five
measurements. All other data points represent a single determina-
tion.
dissociation constant was 1-2 nM. When a 50-fold excess of
unlabeled EGF was added at 4°C, 90% of the "'I-EGF pre-
viously bound was displaced with a tv, of60 min. Dissociation
ofbound ligand was also pH dependent and occurred rapidly
(t,, = 2-3 min) in the absence of excess EGF or calcium ions.
At pH 6, 50% of the prebound ligand was released, while 90%
was removed at pH 4.5-5.5 (Fig. 2A). Therefore, acid treat-
ment (pH 5.0) for 10 min at 4°C was used as a measure of
surface-bound EGF. This treatment had no significant effect
on cell morphology (data not shown) nor on subsequentEGF
binding (Fig. 2B) or uptake.
We next characterized EGF binding in liver homogenates
(Fig. 1) and found 300,000 high-affinity sites of Kd = 8-15
nM by Scatchard analysis with no low-affinity sites (Fig. 1,
inset). In addition, we found that 10-20% of the available
binding sites in a liver homogenate were unstable to storagem
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FIGURE 2 The effects of acid treatment on EGF binding in the
perfused liver. The effect of pH on the release of prebound EGF
(A) and on subsequent EGF binding (B) was examined in the
perfused liver. (A) '251-EGF (8 nM) was recirculated for 90 min
through an isolated liver at 4°C, after which the perfusate was
replaced with fresh medium (4°C) with (0) or without (p) 2.2 mM
CaCl2 at the indicated pH. The buffers used were 20 mM HEPES
(pH 7.4), 20 mM PIPES (pH 6.0-6.5), and 40 mM acetate or citrate
(pH 5.0-5.8). The amount of EGF released at a particular pH was
calculated from the increase in radioactivity in the medium after 15
min of perfusion and expressed as a percent of the radioactivity
initially cleared from the perfusate and bound by the liver. (B) We
examined the clearance of 1251-EGF (8 nM) at 4°C by taking aliquots
of perfusate at selected times after the addition of ligand and
measuring the radioactivity present ("). Maximum binding of ligand
by hepatocytes was achieved by 60-90 min at which time the
medium was acidified to pH 5.0 by the addition of 5 ml of 1 M
sodium acetate-buffered perfusate (pH 3.5) (arrow). After washing
the liver free of acidic medium using fresh perfusate at 4°C, we
added a second bolus of 1251-EGF and determined the clearance of
ligand from the perfusion medium (O).
on ice for 4-6 h or to freeze/thawing. For this reason binding
assays were performed, when possible, on fresh homogenates.
In an effort to assay active receptors in a latent (intracellu-
lar) compartment, various detergents were screened for their
ability to maintain EGF binding in liver homogenates (Fig.
3). The following detergents at final concentrations of 0.2-
0.6% resulted in an almost total inhibition of EGF binding in
the liver homogenate and were considered inappropriate for
measuring intracellular receptors: digitonin, Triton X-100, 2-
deoxycholate, Lubrol WX, and 3-[(3-cholamidopropyl) di-
methylammoniol]-1-propane-sulfonate (CHAPS). Only the
nonionic detergent, Brij 35, at concentrations of 0.3-0.7%,
had no effect on receptor number in homogenates of freshly-
isolated livers, but decreased receptor affinity (Kd = 25 nm).
The finding that Brij 35 did not increase the specific binding
of "'I-EGF in freshly prepared liver homogenates, even at
concentrations as low as 0.05%, suggested that all 300,000
receptors per cell were in an accessible compartment (i.e., at
the cell surface).
Cytochemical Localization of EGF in the
EGF covalently coupled to HRP (EGF-HRP) was used to
visualize the distribution of EGF binding sites at the cell
surface (i.e, 4°C binding) and to investigate the route of ligand
entry. At 4°C peroxidase reaction product was distributed
along microvilli of the sinusoidal front and the lateral surface
membrane ofhepatocytes with some concentration in coated
pit regions (Fig. 4). Although we did observe EGF-HRP
binding to nonparenchymal cells, the reaction product was
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FIGURE 3 The effects of detergents on EGF binding in liver ho-
mogenates. Homogenates were incubated for 60 min at 4°C in the
presence of 80 nM'251-EGF and selected detergents at the indicated
concentrations (wt/wt). Specific EGF binding was calculated as
described in Materials and Methods and expressed as a percentage
of EGF-binding capacity measured in the absence of detergent.
When error bars are present, the value is an average t SEM of four
to eight determinations. All other data points represent a single
measurement. TX 100, Triton X-100; LUB WX, Lubrol WX; DIG,
digitonin; DOC, 2-deoxycholate.
light and variable. When a 50-fold molar excess of EGF was
perfused with EGF-HRP, the conjugate was not bound (as
detected by the "'I-EGF moiety) and no HRP reaction prod-
uct was observed on parenchymal or nonparenchymal cells.
To investigate the route of ligand entry into the cell, EGF-
HRP was first perfused through a liver at 4°C. Unbound
ligand was then washed away and the medium was rapidly
warmed to 35°C for 2, 4, or 10-25 min. The HRP reaction
product was almost exclusively associated with hepatocytes,
demonstrating that liver parenchymal cells were responsible
for the endocytosis ofEGF. The HRP-positive structures were
characterized morphologically (Fig. 5) and quantitated at
selected times afterwarming (Table I). At 2 min, HRP product
was predominantly localized in structures similar in size (50-
100 nm) and shape to coated pits and vesicles (80% of the
positive structures counted) (Table I and Fig. 5a). However,
clathrin coats were not visible underthe conditions offixation
and HRP visualization. Reaction product was absent from
both the microvilli and lateral surfaces. By 4 min, HRP-
positive structures included larger vesicles and tubules (100-
200 nm diam) in addition to coated pits and vesicles (Fig. 5,
b and c and Table 1). These larger structures, which accounted
for -50% of the positive vesicles observed, were located at
the cell periphery and were morphologically identical to type
I endosomes as previously described for the endocytosis of
ASGPs (41, 42). In fact, when EGF-HRP was perfused in the
presence ofasialoorosomucoid adsorbed to colloidal gold, 60-
75% of the HRP-positive vesicles contained the gold tracer
(A. L. Hubbard and W. A. Dunn, unpublished results). After
10-25 min of perfusion at 35°C, 66-85% of the vesicles
containing HRP product were located in the Golgiapparatus-
lysosome region of the cell (Fig. 5, d-f). These vesicles
included small and large vesicles and tubules (type II endo-
somes, see references 41 and 42) and structures containing
either lipoproteins or small vesicles (type III endosomes,
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￿
Surface distribution and specificity of EGF-HRP binding in the perfused liver. The distribution of EGF-HRP binding at
4°C to the cell surface was visualized as described in Materials and Methods (a and b) . The reaction productwas localized along
microvilli of the sinusoidal front (SF), in coated pits (arrowheads), and along lateral surfaces (LS) of hepatocytes . Endothelial cells
lining the sinusoidal lumen (SL) were found unlabeled . (c) When a 50-fold excess of unlabeled EGF was perfused along with
EGF-HRP, no labeling of the hepatocyte plasma membrane was observed . Bar, 0.5 jum. (a-c) x 25,000 .
references 41 and 42) . At this time, 1211-EGF was not yet
present in lysosomes but was still in a prelysosomal compart-
ment as analyzed by subcellular fractionation (see below) .
Kinetics and Extent of EGF Uptake
" II-EGF concentrations from 0.5-40 nM were continu-
ously perfused through livers for up to 4 h and the disappear-
ance of acid-insoluble radioactivity from the medium was
monitored over time. The clearance curves of "'I-EGF at
three representative concentrations are plotted in Fig. 6 . At
subsaturating levels (0.5 nM), >90% of the added "'I-EGF
was cleared by 20 min . At intermediate and saturating EGF
concentrations (5 and 20 nM) the clearance was biphasic,
with a fast primary phase that abruptly changed at 15-20 min
to a slower secondary phase. When the primary clearance
phase (0-15 min) at these three concentrations was plotted
semilogarithmically, straight lines were obtained (Fig. 6, in-
set) . The rates of this initial uptake were calculated from the
slopes and are presented in Fig . 7 . From 0.06-1.5 Ag EGF/g
liver, the rate of uptake increased concentrations of ligand . A
double-reciprocal plot of the data indicated that the half-
maximal clearance rate was obtained at 5 nM EGF. A maxi-
mal primary rate of 20,000 molecules/cell per min occurred
at - 1 .5 ug EGF added per gram liver (15 nM) and remained
unchanged up to 4.0 ;Lg/g (40 nM).
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When the added levels ofEGF were >0.5 ug/g (5 nM), the
primary uptake was followed by a slower secondary clearance
that was linear from -30 min to at least 240 min (Fig . 6) .
The rate of uptake increased with increasing ligand input to
a maximal level of 2,500 molecules of EGF/min per cell at
an EGF dose of -1 .4 Ag/g liver (Fig . 7). This rate was 12-
13% of that observed for the primary clearance and, as will
be discussed below, equalled the rate ofrelease ofacid-soluble
radioactivity from the liver.'
The amount ofligand internalized (i.e ., inaccessible to acid
release) as a function of time was quantitated using saturating
doses of EGF (>1 .4 lug/g) and expressed on a per cell basis
(Fig . 8) . A rapid accumulation of 250,000 molecules/cell
occurred during the first 20 min ofEGF exposure . This was
followed by a slower uptake ofligand which was linear for up
to 4 h . The amount of EGF internalized at 4 h was three
2 Thesecondary clearance phasewasnot due to EGF uptake by other
cell types, since only hepatocytes possessed the ability to endocytose
EGF. In addition, the secondary rate ofuptake, although slower than
the primary clearance, was rapid and saturable, two characteristics of
receptor-mediated endocytosis, not fluid-phase pinocytosis (43) . Fi-
nally, the difference between the primary and secondary rates of
ligand uptake was not due to changes in EGFconcentrations in the
perfusate nor in receptor K d values, but the result of a decrease in
hepatocyte cell surface receptors .FIGURE 5
￿
Intracellular localization of EGF-HRP in hepatocytes at 2 min (a), 4 min (b and c), and 10-25 min (d-f) after ligand
internalization . An experimental protocol was used such that a single wave of EGF-HRP movement from the cell surface to the
lysosomes could be visualized with time (see Materials and Methods) . (a) 2 min after warming, EGF-HRP was near the plasma
membrane in structures similar in dimensions to coated pits and vesicles (arrowheads) . (b and c) By 4 min, HRP-positive structures
included larger vesicles and tubules (type I endosomes, En I) in addition to coated pits and vesicles (arrowheads) . (d-f) When the
liver was warmed for 10-25 min, the HRP product was located in the Golgi-lysosome region of the cell in small and large vesicles
and tubules designated endosomes type II (En 11) and in structures resembling either lipoprotein-containing vesicles or multive-
sicular bodies, designated endosomes type III (En 111) . GO, Golgi apparatus ; AV, autophagic vacuoles . Bar, 0.5 jAm . (a-f) x 25,000 .
times the total number of EGF binding sites in liver homog-
enates (Fig. 1) . Cycloheximide (0.2-1 mM) at concentrations
shown by others to inhibit protein synthesis in the perfused
rat liver (44) had no effect on theamount ofEGF internalized
over a 4-h period .
Kinetics and Extent of EGF Degradation
No acid-soluble radioactivity appeared in the perfusate until
20 min, after which it increased linearly for up to 240 min
(Fig. 6) . Analysis by column chromatography revealed that
the released radioactivity was free iodide . Since no significant
accumulation of acid-soluble radioactivity was evident in the
liver,we used the rate ofincrease ofacid-soluble radioactivity
in the perfusate to estimate the rate of hydrolysis ofEGF by
hepatocytes (Fig . 7) .
As shown in Fig . 7, the rate of hydrolysis increased with
EGF concentration up to - 1 .4,ug/g liver (14 nM) and there-
after remained unchanged at a maximum of 2,500 molecules
of EGF degraded/min per cell . By analyzing this data on a
double-reciprocal plot (not shown), the EGF concentration
necessary for a half-maximal degradative rate was 7 nM,
which was comparable to that observed for the primary phase
of uptake (i.e ., 5 nM) .
The maximal rate of release of acid-soluble radioactivity
from the liver was identical to the maximal rate observed for
the secondary phase ofEGF uptake, 2,500 molecules/cell per
min, suggesting establishment of a steady state. Indeed, as
shown in Fig . 8, after 20 min of perfusion with saturating
levels of EGF (>1.4 /Ag/g), a steady state was reached such
that the amount of EGF internalized paralleled that which
was degraded . The difference between the amount of EGF
internalized and degraded remained constant from 20 to 240
min and represented an intracellular pool of 200,000 ligand
molecules/cell, which was comparable to the amount ofEGF
internalized in the initial uptake phase, from 0-20 min .
Finally, we measured the amount ofEGF hydrolyzed under
saturating conditions . These results are presented in Fig. 8 .
After the initial 20-min lag, the amounts of EGF degraded
increased linearly to a total of 690,000 molecules/cell at 4 h.
This represents 2.3 timesmore ligand than the initial number
of total available receptors measured in the liver homogenate.
In addition, the amount of EGF degraded within 4 h was
unaltered when protein synthesis was inhibited by 0.2-1 mM
cycloheximide .
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TABLE I
Intracellular Region*
Peripheral Cyto-
￿
Golgi-lysosome
plasm
￿
region
Fate of EGF Receptor during Endocytosis
The number of structures containing EGF-HRP in the indicated regions of
the hepatocyte was determined without regard to size, and the percent
distribution was calculated.
= This category contains structures of size (50-100nm) and shape similar to
those of coated pits and vesicles. However, clathrin coats were not visible
under the conditions of fixation and HRP visualization; therefore, some
type I endosomes, En l, may have been included in this category.
' Endosomes were classified as type I (peripheral vesicles and tubules <200
nm diam); type II, En ll, (small vesicles and tubules in the Golgi-lysosome
region; and type III, En Ill, (large, >200 nm diam) vesicles in the Golgi-
lysosome region usually containing distinguishable smaller vesicles or other
inclusions). (Refer to Fig. 5.)
~ Sum of endosomes type II and III.
20 40 60 80 100 120 140 160 180 200 220
Time (min)
240
FIGURE 6 Clearance at 37°C of different concentrations of 'zsl-
EGF from the perfusion medium and accumulation of acid-soluble
radioactivity in the perfusate. At the indicated times after addition
of 0.5 nM (90,000 cpm/ng) (O), 5 nM (9,000 cpm/ng) (p), or 20 nM
(2,250 cpm/ng) (p, ")'zsl-EGF, aliquots of perfusate were removed
and precipitated with TCA as described in Materials and Methods,
and the acid-insoluble radioactivity (open symbols) was plotted.
When the primary rapid clearance phase at each concentration was
plotted using the log of the radioactivity, straight lines were ob-
tained with linear regression correlations of 0.96 ± 0.03 (inset). The
acid-soluble radioactivity (") released from a liver exposed to 20
mM ligand accumulated in the circulating medium as a function of
time after a lag of 20 min.
At selected times afteraddition of saturating doses of EGF,
livers were homogenized and homogenates were assayed for
accessible (minus Brij 35) and latent receptors (plus Brij 35)
2154
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME IS, 1984
to zo so ao
EGF (nM)
FIGURE 7
￿
The effect of EGF concentration on the rates of primary
and secondary clearance and on the rate of release of degradation
products. Selected concentrations of "'I-EGF were recirculated
through perfused livers for up to 4 h and the clearance of ligand
and subsequent release of radiolabeled products was measured.
The rate of the primary clearance phase at each concentration was
determined by multiplyingthe ligand input by the slope of a semilog
plot of the acid-insoluble radioactivity in the perfusate at 0-15 min
(Fig. 6, inset). The rates of the secondary clearance phase and of
degradation were calculated from the specific radioactivities of the
ligand and the slopes of the linear plots of the acid-insoluble and
soluble radioactivity, respectively, in the perfusate from 30-240
min (Fig. 6).
as described in Materials and Methods. These results are
presented in Fig. 8. Prior to EGF exposure the number of
accessible and total receptors was the same, indicating the
absence of a substantial intracellular pool. However, in the
presence of EGF, a rapid decrease in accessible binding activ-
ity was observed which was coincident with an increase in
latent binding.' Total binding activity (accessible plus latent)
remained constant for up to 2 h and then declined to 70% of
initial values by 4 h.
Between 4 and 20 min after EGF addition, when ligand
was beingrapidly internalized but not yet degraded, there was
a progressive and rapid loss of up to 80% of the accessible
binding activity (Fig. 8).° This decrease in accessible receptors
coincided in time and amount with both an increase in latent
binding activity and with the internalization of EGF. For
example, when 250,000 molecules of EGF had been internal-
ized per cell by 20 min, the number of accessible receptors
decreased and that of latent receptors increased by approxi-
mately 200,000 per cell (65-70% of total).
At times longer than 20 min, when the rates of internali-
zation and degradation of EGF had reached steady state, the
number of accessible receptors remained constant at 50-
60,000 receptors per cell, which represented 20% ofthe recep-
tors initially accessible (Fig. 8). This 80% reduction coincided
with a similar reduction in the rate of EGF uptake observed
' Accessible (nonlatent) receptors are those EGF-binding sites mea-
sured in the absence of Brij 35 detergent and are presumed to be
located at the cell surface (see Results). Total functional receptors are
determined in the presence of detergent and equal the sum of the
accessible and latent receptors present. Latent receptors are presumed
to be oriented towards the lumen ofintact vesicles andthus incapable
ofbinding added EGF without detergent permeabilization.
" EGF binding at 4°C in the perfused liver showed a trend similar to
that seen for accessible receptors (i.e., 85% decrease within 20-60
min) but always yielded values that were 40-50% ofthose calculated
in vitro in the absence of detergent.
warming
to 31-
32°C
min
Total
structures
counted
Pits and
small
vesicles
%
En IS En II'
%
En III'
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4 527 28 49 18 (23)1 5
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(66)
12
15 459 12 16 56
(72)
16
25 344 4 11 50
(85)
35J
J
w
U
Cr
w
Ct
n
O_
X
w
J
U
W
J
O
20 40 60
during steady state (Fig. 7). Latent receptors remained at
-230,000/cell for up to 2 h and then declined to 150,000/
cell at 4 h. Furthermore, the number of total receptors re-
mained the same for up to 2 h despite the degradation of
substantial amounts of EGF during this time. Throughout
the next 2 h, only 0.3 receptor sites were inactivated per
molecule of EGF degraded (90,000 receptors lost per cell vs.
320,000 molecules degraded per cell, Fig. 8).
When livers were perfused in the absence of EGF for 4 h
and the receptors were quantitated (Fig. 8), accessible recep-
tors decreased to 210,000/cell (70% of initial), but total
receptor number remained virtually unchanged (280,000 ±
36,000 receptors per cell). Therefore, the decrease in receptor
number was due to the presence of EGF not cell dysfunction
brought about by the perfusion conditions. However, 30% of
the initially accessible receptors were transferred to a latent
pool even in the absence of ligand.
Subcellular Distribution of EGF and Its Receptor
Livers were perfused with 'ZSI-EGF either at 4°C for 90 min
(to label the cell surface), at 35°C for 10-20 min when ligand
degradation was not yet evident (to label the contents of
endosomes I-III), or at 35°C for 120 min when ligand degra-
dation was occurring (to possibly label the contents of lyso-
somes). Livers were then homogenized and three fractions
were prepared: material sedimenting at 12,000 g (the 12-K
fraction) or at 145,000 g (the microsomal fraction), and
material remaining in the 145,000 g supernatant (the cytosolic
fraction). The 12-K and microsomal fractions were subfrac-
tionated on continuous sucrose gradients. The distributions
of bound or sequestered EGF and of accessible and/or total
EGF binding activities were determined in the three subcel-
+C~
O
FIGURE 8 The uptake and degra-
dation of EGF and effects on recep-
tor number. At selected times (4-
240 min) after the addition of satu-
rating amounts of '251-EGF (>1 .4 rag/
g), whole livers and/or biopsies
were homogenized in SI . Total acid-
insoluble and -soluble radioactivity
in the perfusate and liver was deter-
mined as described in Materials and
Methods. Total EGF internalized (0)
equaled TCA-soluble radioactivity
in the perfusate plus total radioac-
tivity in the liver. Combined TCA-
TI ME (min)
￿
soluble radioactivity in the liver and
perfusate yielded the total EGF degraded (0). Cycloheximide (CHX; 0, Op) at concentrations of 0.2-1 mM was perfused through
a liver for 30 min prior to ligand addition. EGF binding capacity was measured in the absence (accessible; A) or presence (total)
of 0.4-0.7% Brij-35 detergent (detergent to protein ratio of 0.4-1 [wt/wt]) as described in Materials and Methods. Latent receptors
(A) were calculated from the difference in total and accessible receptors. To insure optimal recovery of latent receptors, we
routinely used four to six detergent concentrations for each determination. Measurements of EGF binding capacity involved
assaying unoccupied receptor sites in homogenates of livers that had previously been exposed to '251-EGF. However, any potential
problems introduced by the presence of sequestered ligand were eliminated by the assay conditions. This was accomplished
using '251-EGF of 10-fold higher specific activity and an amount that exceeded that of the sequestered ligand by a factor of ten.
In addition, Brij 35 released at least 75% of the sequestered EGF within 60 min (the length of the incubation), thereby exposing
latent receptors (data not shown). Thus, the presence of sequestered ligand did not interfere with an accurate measurement of
total receptor number. The amount of EGF bound per aliquot was converted to receptors per cell using 1 .38 X 108 cells/g liver
or 1 x 106 cells/mg protein . Since the liver retained interstitial fluid with time of perfusion (26), we found it necessary to
standardize our results by expressing the homogenates in units of mg protein/ml instead of g liver/ml. In addition, the effects of
long-term perfusion on receptor number were determined in the absence of EGF (A A). When standard error bars are present,
the value is an average ± SEM of at least four measurements. All other data points represent a single determination .
-- EGF
-,,--ACCESSIBLE RECEPTORS
￿
---
120 180 240
lularfractions as well as in the sucrose gradients and compared
with those of conventional enzyme markers for the plasma
membrane (5'-NUC and APDE), Golgi apparatus (Gal-
Trans), and lysosomes (a-NAG) (Figs. 9 and 10). Enzyme
markers for plasma membrane and Golgi apparatus were
equally distributed between the 12-K and microsomal frac-
tions, while lysosomes were predominantly located in the 12-
K fraction (80% of (#-NAG activity). Less than 5% of any of
the enzyme activities remained in the cytosolic fraction.
DISTRIBUTION OF LIGAND AT 0-20 MIN AFTER EX-
POSURE TO EGF: When fractions from livers exposed to
"'I-EGF at 4°C (surface-bound) were examined, -20% ofthe
ligand did not sediment, suggesting release. However, the
remaining 80% was equally divided between the two sedi-
mentable fractions. As described in the morphology section,
10-25 min afterexposure to EGF-HRP, many endosomes (II
+ III) containing ligand were located within the peribiliary
region (Table I and Fig. 5). Fractionation of homogenates
from comparable livers exposed to 121I-EGF for 10-20 min
revealed that 78-96% of the homogenate radioactivity was
associated with vesicles that sedimented at 12,000 g (20-51 %)
or 145,000 g (45-58%). The equal distribution of bound or
sequestered ligand between the 12-K and microsomal frac-
tions was not coincident with a-NAG activities but did resem-
ble that seen for Gal-Trans, 5'-NUC, and APDE activities.
The heterogeneous composition of the two sedimentable
fractions prompted us to resolve the different subpopulations
(i.e., plasma membrane, lysosomes, Golgi apparatus, and
endosomes) by isopycnic centrifugation on sucrose gradients
(Figs. 9 and 10). The distribution of surface-bound EGF (i.e.,
90 min, 4°C) was examined first. "'I-EGF that sedimented
with the microsomal fraction equilibrated as a single band on
sucrose gradients at a peak density of 1 .15 g/cc (Fig. 10). This
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FIGURE 9 Distribution on sucrose gradients of sequestered EGF
and of EGF receptors in the 12-K fraction. Livers were either
perfused with saline (0 min, control) or perfused at 35°C with 20
nM 1251-EGF for 10-20 min or 120 min. 12-K fractions were obtained
and further fractionated on continuous sucrose gradients as de-
scribed in Materials and Methods. EGF-binding activity in 0.1-ml
aliquots was measured in the absence or presence of detergent.
Owing to the lower protein content in these samples as compared
with liver homogenates, 0.2% Brij 35 was sufficient for measuring
maximal EGF binding.
peak was coincident with that of the plasma membrane
markers, 5'-NUC and APDE (latter enzyme not shown). We
then examined the behavior of EGF-containing vesicles or
endosomes (i.e., 10-20 min, 37°C) on sucrose gradients. 90%
of the radioactivity applied entered the gradients and none
coincided with the lysosomes (1 .18-1 .25 g/cc) (Figs. 9 and
10). Only -20% of the radioactivity distributed at densities
corresponding to the plasma membrane (1.14-1 .17 g/cc, Figs.
9 and 10), which was consistent with the amount of residual
1251-EGF bound to the surface. At least 70% of the ligand-
containing vesicles migrated at densities between 1 .08 and
1 .13 g/cc. These vesicles were well-separated from the bulk of
the protein (80%) and from at least 70% of the 5'-NUC and
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FIGURE 10
￿
Distribution on sucrose gradients of sequestered EGF
and of EGF receptors in the microsomal fraction. Livers were either
perfused with saline (0 min, control), perfused at 4°C with 8 nM
'251-EGF for 90 min (0 min), or perfused at 35°C with 20 nM 1251_
EGF for 10-20 min or 120 min. Microsomal fractions were obtained
and further fractionated on continuous sucrose gradients as de-
scribed in Materials and Methods. EGF-binding activity in 0.1-ml
aliquots was measured in the absence or presence of 0.2% Brij 35.
APDE activities. The behavior of Gal-Trans activity was
similar but not identical to that of endosomes. That is, Gal-
Trans distributed at higher densities (1 .11-1 .16 g/cc) than
those seen for the 1251-EGF-labeled endosomes. Although still
contaminated with other organelles, a 10-20-fold purification
of the endosomes was accomplished with this procedure.
DISTRIBUTION OF LIGAND AT LATER TIMES: When
the subcellular distribution of sequestered 1251-EGF from liv-
ers exposed to the ligand for 120 min was examined, 30% of
the homogenate radioactivity sedimented at 12,000 g and
48% at 145,000 g. Subfractionation on sucrose gradients
revealed that the bulk of the sequestered 1251-EGF at these
later times was still in endosomes, not in lysosomes. Of the
radioactivity present in the 12-K fractions, 40% equilibrated
at densities of 1.08-1 .13 g/cc, 29% at 1 .14-1 .17 g/cc (i.e.,
plasma membrane), and only 21% (6% of liver radioactivity)
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4at 1.18-1 .25 9/cc (i.e., lysosomas). The 'ZSI-EGF in the micro-
somal fraction was distributed between the endosome-rich
peak (70%) and the plasma membrane peak (20%).
SUBCELLULAR DISTRIBUTION OF EGF-BINDING AC-
TIVITY BEFORE AND AFTER EGF EXPOSURE : We first
examined EGF receptor distribution in livers that had not
been exposed to ligand. 85-90% of the EGF receptor was
sedimentable and accessible to ligand binding (i.e., EGF bind-
ing t detergent was the same). The membrane-associated
receptor was equally distributed between the 12-K and micro-
somal fractions. Analysis of these fractions on sucrose gra-
dients (Figs. 9 and 10) revealed in both cases that EGF-
binding activity coincided with the plasma membrane marker
enzymes (5'-NLJC and APDE). Over 80% of the total binding
activity applied to the sucrose gradient could be recovered
and only 5% ofthis activity failed to enter the gradient.
After exposure of livers to EGF for only 10-20 min, as
much as 80% of the total receptors were localized to a latent
pool (Fig. 8). When total EGF binding (i.e., nonlatent and
latent) was measured in fractions from liver homogenates
prepared 10-20 or 120 min after EGF addition, 20-50%
sedimented at 12,000 g, 45-58% sedimented at 145,000 g,
and <5% was nonsedimentable. When the 12-K and micro-
somal fractions were analyzed on sucrose gradients, we found
that the receptors had shifted to a lighter density (1.08-1 .13
g/cc, Figs. 9 and 10). As much as 70% of the total EGF-
binding activity recovered now co-localized with the EGF-
containing vesicles, not with the plasma membrane. Of the
receptors that equilibrated in this region of the gradient (i.e.,
endosomes), 40-80% displayed latency. In contrast, the bulk
of the accessible receptors (20% of the total receptors) equili-
brated with the plasma membrane markers and presumably
represented those receptors still at the cell surface.
At 120 min but not 10-20 min afterEGF addition, a small
fraction of the EGF-binding activity was detected at densities
correspondingto lysosomes (1 .18-1 .25 g/cc, Fig. 9). However,
due to the limitations of the binding assay, samples with a
low capacity to bind EGF (<3 ng EGF bound/ml) were
difficult to measure accurately. For this reason the presence
ofEGF receptors in the lysosomes couldnot be demonstrated
conclusively.
Effects of Leupeptin on the Metabolism
of 1251-EGF
We found little EGF accumulating in hepatic lysosomes at
any time despite extensive hydrolysis of the ligand. Although
a similar result for asialofetuin has been reported (23), indi-
cating a very efficient lysosomal system in hepatocytes, we
wanted to determine whether lysosomes were responsible for
the degradation of EGF. Therefore, we used leupeptin, a
proteinase inhibitor that has been shown to inhibit the deg-
radation of asialofetuin resulting in its accumulation in lyso-
somes (23). We found that 0.4 mM leupeptin had no effect
on EGF uptake but inhibited the rate ofrelease ofacid-soluble
radioactivity by as much as 80% . In the presence ofleupeptin,
there were 340,000 molecules of EGF per hepatocyte at 2 h
and 440,000 molecules per hepatocyte at 4 h, as compared
with 200,000 molecules in the untreated cell at steady-state.
Subcellular fractionation of leupeptin-treated livers revealed
an increase in EGF content in the 12-K and cytosolic fractions
(Table II). The increased level of EGF present in this latter
fraction was probably due to breakage during homogenization
DISCUSSION
TABLE II
Effect of Leupeptin on the Subcellular Distribution of 'ZS/-EGF in
the Liver*
* Isolated livers were perfused in the absence or presence of leupeptin (0.4
mM)for 15 min before addition of 'ZSl-EGF (15 nM). After 2 h of perfusion
at 35°C, the livers were homogenized in cold SI and separated into the
three fractions indicated. Theacid-insoluble radioactivity in these fractions
and in the total homogenate were then determined and expressed as
micrograms of EGF. The 12-K fraction was analyzed on sucrose gradients,
the "51 found in the density ranges corresponding to endosomes, plasma
membranes, and lysosomes (see Fig. 9) was determined, and the results
were expressed as micrograms of EGF.
of the enlarged lysosomes in leupeptin-treated livers (45).
Analysis of the 12-K fraction on a sucrose gradient revealed
that 50% of the '2'1-EGF migrated in the density range of
lysosomes (1.18-1.25 g/cc, Fig. 9). Furthermore, the amount
of 'ZSI-EGF co-migrating with lysosomes in leupeptin-treated
livers was increased sevenfold over that ofcontrols (Table II).
In this study, we have demonstrated that rat hepatocytes
possess many EGF receptors that mediate the endocytosis of
substantial amounts of circulating EGF. We found that EGF
is internalized and transported to lysosomes via the same
pathway as that used by other ligands destined for hydrolysis
in hepatocytes. Concomitant with the initial wave of EGF
internalization there is the redistribution of an equivalent
number of receptors from the cell surface to endosomes but
apparently not to lysosomes. However, unlike the ligand,
which is degraded, our results suggest that a majority of the
internalized receptors are reutilized. Furthermore, indirect
evidence presented here suggests that at steady statethe rates
of uptake and degradation of EGF are dependent on the rate
of receptor insertion into the plasma membrane and the rate
of endosome/lysosome fusion, respectively.
Exposure to EGF Induces a Rapid Disappearance
of Cell Surface EGF Receptors
We measured 150,000 receptors per cell in the perfused
liver and 300,000 receptors per cell in vitro. At present we
don't understandthe basis for this two-fold difference, but we
believe, for several reasons, that the increased number found
in liver homogenates represents receptors at the plasma mem-
braneand not those in an intracellular pool. First, the binding
in naive cellsdisplays no latency, whereas we can detect latent
receptors in cells actively endocytosing EGF. Second, all the
binding activity in naive cells migrates on sucrose gradients
with conventional plasma membrane markers, not internal
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Sucrose gradient (glcc)
1 .14-1 .17 1 .18-
1 .08-1 .13 (Plasma 1 .25
Experi- (Endo- mem- (Lyso-
ment Fraction somes) branes) somes)
kg EGF jug EGF ug EGF wg EGF
Control 12 K 0.52 0.26 0.20 0.13
Microsomal 0.87
Cytosoiic 0.17
Total 1 .70
Leupeptin 12 K 1 .95 0.58 0.42 0.94
Microsomal 0.90
Cytosolic 0.91
Total 3.94membrane markers. Finally, the initial rapid wave of EGF
clearance results in the uptake of about 300,000 ligand mol-
ecules, suggesting that all the receptors detected in vitro
(300,000/cell) are in a functionally equivalent pool or site.
Upon addition of EGF to a perfused liver, we observed a
rapid and dramatic disappearance of cell surface EGF recep-
torsthat closely paralleled the internalization ofligand in both
time and extent. The number of surface receptors decreased
by 80% within 20 min and remained at this low level for up
to 4 h. Furthermore, the observed down-regulation of EGF
receptors at the surface coincided with the appearance of an
internal pool of receptors having the biochemical character-
istics of endosomes. Thus, one wave of EGF internalization
was sufficient to induce a massive redistribution of receptors
and to establish a new equilibrium such that only 20% of the
EGF receptors remained at the cell surface and 80% were
within endosomes.
Receptor down-regulation has been described previously
for EGF as well as for hormones (e.g., insulin [12, 13]) in
hepatocytes and other cells (7-11). However, the mecha-
nism(s) of EGF receptor down-regulation (redistribution and/
or degradation) have not yet been resolved. Das and Fox (8)
and Krupp et al. (10) concluded that receptor degradation
accounted for down-regulation in 3T3 and A431 cells, respec-
tively. In contrast, Wiley and Cunningham (11) used a math-
ematical modeling approach to analyze EGF endocytosis at
steady state in 3T3 cellsand concluded that down-regulation
was the result ofan increased rate ofreceptor internalization.
We were able to follow the EGF receptor into the cell and
demonstrate that down-regulation in hepatocytes was due to
a rapid and substantial redistribution, not degradation, of
receptors.
Pre-existing EGF Receptors Are Reutilized
We found that hepatocytes were able to internalize and
degrade EGF well in excess oftotalfunctional receptors. Since
this occurred in the absence of new receptor synthesis, reuti-
lization of pre-existing receptors must have occurred. Recep-
tor reutilization has been implicated in the endocytosis of
several other ligands, such asa2-macroglobulin-protease com-
plexes and mannose glycoconjugates in alveolar macrophages
(46, 47), LDLs lipoproteins in fibroblasts (1, 5), and ASGPs
and insulin in liver (6, 48). However, the evidence that
receptors actually disappear from the cell surface in the proc-
ess of internalizing ligand and then return (i.e., recycle) for
further rounds of internalization is still indirect. Our obser-
vations that surface EGF receptors are initially internalized
into vesicles similar to endosomes and continue to be found
in these vesicles during the steady state that follows, together
with our evidence for reutilization, suggest strongly that EGF
receptors are recycled between surface and intracellular sites.
The processes required for return of internalized receptors
to the plasma membrane are (a) dissociation of the ligand-
receptor complex; (b) separation of the receptor from ligand-
containing vesicles; (c) transport to the plasma membrane;
and (d) insertion. We have shown that dissociation of the
EGF receptor complex can occur at low pH (Fig. 2A), an
environment that exists in endosomes of other cells (49, 50)
and lysosomes of liver (51). The observation of Fitzgerald et
al. (52) that EGF was released into the cytosol when adeno-
virus induced endosome lysis suggests that the ligand had
dissociated from its receptor while in a prelysosomal com-
partment. In contrast, on the basis of a close association of
2158
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 98, 1984
internalized EGF-ferritin with the membrane, McKanna et
al. (53) suggested that EGF remained bound to its receptor
until entry into lysosomes. We have found that the amount
of EGF internalized by hepatocytes at 16°C, a temperature
that inhibits endosome-lysosome fusion in liver(24), is lim-
ited and equals the total complement of EGF receptors, that
surface receptors are depleted by >90% at 16°C, and that an
equivalent number of latent receptors appears in endosomes
at this temperature (W. A. Dunn and A. L. Hubbard, unpub-
lished observations). These results suggest that entry of the
EGF receptor into lysosomes (whether bound to ligand or
free) may be a prerequisite for recycling. Furthermore, the
existence of large amounts of undegraded EGF, apparently
together with receptor in endosomes at steady state at 37°C,
again suggests that entry into lysosomes may be the rate-
limiting step for both EGF degradation and for return of
receptor to the plasma membrane. An alternate possibility
which might account for the excess of EGF internalized over
receptors measured would be activation ofpreviously inactive
receptors in response to EGF exposure. However, until im-
munological reagents are obtained and the existence of an
inactive pool ofreceptors in hepatocytes can be evaluated, we
believe receptor reutilization and recycling adequately explain
our data.
After the initial wave of receptor and EGF internalization,
we found that the number of surface receptors in hepatocytes
remained constant despite continued EGF endocytosis. Thus,
the rate of insertion of recycling receptors from the internal
pool must have equaled the rate of EGF uptake, which was
2,500 molecules/min per cell. Since the clearance rate ofEGF
at steady state appeared to be zero-order, either insertion of
unoccupied receptor or internalization of the ligand-receptor
complex must have been rate limiting, not binding of EGF to
receptor, at least at the saturating EGF concentrations we
used. Wiley and Cunningham (11) estimated that 320 EGF
receptors were inserted into the plasma membrane per min
per cell at steady state in fibroblasts, but the origin of these
receptors (recycled vs. newly synthesized) was not determined.
From our studies with the perfused liver we conclude that
receptor recycling is occurring during the continual uptake of
EGF and propose that the rate of ligand clearance at steady
state is governed by the rate ofinsertion of receptors into the
plasma membrane. Furthermore, this rate must be 2,500/min
per cell, a value 10 times higher than that calculated for EGF
receptor insertion in fibroblasts (11).
Degradation of EGF by Hepatocytes
What is the evidence that EGF is degraded within lyso-
somes? Since this ligand was hydrolyzed rapidly by hepato-
cytes once it reached a degradative compartment, it was
difficult to detect significant amounts of intact or even par-
tially degraded "'I-EGF within these structures. Similar ob-
servations were reported for asialofetuin (23). However, we
found that leupeptin, a potent inhibitor of lysosomal cathep-
sins B and L (54), inhibited EGFdegradation by 80% resulting
in the accumulation of ligand in lysosomes. In addition, other
studies have reported EGF entry into structures identified
morphologically as lysosomes (18, 53). Thus, we believe EGF
hydrolysis occurs within lysosomes subsequentto theirfusion
with endosomes.
Our cytochemical experiments with EGF-HRP revealed
that ligand was transported rapidly from the surface to endo-
somes in the Golgiapparatus-lysosome region of hepatocytes(t,12 = 7-8 min). However, no degradation of ligand was
detected for at least20 min. Subfractionation oflivers exposed
to EGF for 10-20 min demonstrated both ligand and receptor
to be in endosomes not lysosomes. Thus, it would appear that
the delay in entry of ligand into lysosomes is not due to
transport but rather some obligate aging process ofendosomes
II + III, possibly influenced by ligand and/or receptor which
renders the endosome (or some derivative) competent to fuse
with lysosomes. In agreement with such a proposal, we found
that the hydrolysis ofligand was linear with time at all levels
of EGF added, suggesting that this step was governed by a
cellular event that occurred at a constant rate, perhaps entry
into lysosomes. Furthermore, at subsaturating EGF concen-
trations (<14 nM), the rates of hydrolysis were proportional
to the primary rates of ligand internalization but were ap-
proximately Vio those rates. These last two observations are
consistent with the possibility that a constant number of
endosomes (or some derivative) fuse with lysosomes at a
constant rate, regardless of their content of EGF. This possi-
bility is currently beinginvestigated.
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